## Session: Skin Deep Intelligence: How AI Is Transforming Dermatology

* **Speaker**: Dr. Mitanjali Sethy
* **Designation**: Department of Dermatology**
* **Organization**: KIMS, Bhubaneswar

---


## 1.0 Introduction: The Significance of Dermatology and the Role of the Clinician

Dermatology is a field of medicine that extends far beyond the surface-level treatment of skin conditions. As articulated by Dr. Mitanjali Sethy, the skin is one of the most visible and socially significant organs, profoundly impacting a patient's self-esteem, confidence, and mental well-being. The pursuit of clear, healthy skin is not merely a cosmetic concern but is deeply intertwined with social interaction and a person's overall sense of self.

**1.1. The Importance of Skin**

Dr. Sethy's opening remarks underscore that the skin is the organ we present to the world 24/7. Consequently, its condition is directly linked to an individual's self-confidence. While internal health is critical, societal and personal value is often placed on having "spotless" or "glowing" skin, making the health of this organ a vital component of both physical and psychological wellness.

**1.2. The Nature of Dermatological Diagnosis**

Dermatological diagnosis is a highly specialized and visually oriented discipline. Dr. Sethy used the analogy of an "eagle eye" to describe the training clinicians undergo. From their resident days, she explained, they are taught to make their "eyes so sharp" that they can diagnose a condition purely by sight—much like a child is taught to recognize an animal. Unlike many other medical fields that rely on extensive laboratory investigations, dermatologists are trained to make accurate diagnoses by observing lesions, patterns, and textures on the skin's surface. This reliance on visual acuity makes the clinician's experience a paramount factor in achieving a correct diagnosis.

**1.3. The High Stakes of Visual Diagnosis**

The visual nature of dermatology also presents a critical challenge: the potential for a small diagnostic error to have severe, life-altering consequences. Dr. Sethy highlighted the significant risk of misdiagnosing a malignant lesion as a benign one. Such a mistake, she explained, can lead to a "big problem," where a treatable condition can progress unchecked. This high-stakes environment underscores the need for exceptional precision and creates an opening for technologies that can support and enhance clinical judgment. The inherent challenges in the field, therefore, make it particularly ripe for technological innovation.

---

## 2.0 Core Challenges in Modern Dermatological Practice

Despite the specialized expertise of clinicians, several inherent challenges in dermatology create significant hurdles in diagnosis and patient management. These issues range from the subjective nature of visual assessment to systemic pressures on the healthcare system, particularly in the Indian context.

**2.1. Diagnostic Ambiguity and Subjectivity**

Dr. Sethy detailed several key diagnostic challenges that complicate the work of dermatologists, which are rooted in the visual and interpretive nature of the specialty.

* Look-Alike Diseases: She explained that many distinct skin diseases present with remarkably similar visual characteristics. A minor, subtle difference in a lesion's appearance can completely change the diagnosis, treatment plan, and patient outcome.
* Inter-Observer Variation: Diagnosis is often subjective, leading to variations between clinicians. Dr. Sethy emphasized that what one dermatologist sees, a colleague may interpret differently, leading to different conclusions. She noted that a clinician's personal experience is the most critical factor in their ability to make an accurate diagnosis.
* Variations in Skin Color: The appearance of a skin disease can differ significantly across various skin tones and ethnicities. Dr. Sethy noted a specific detail crucial to the Indian context: "Our skin color is somehow between the Caucasians and African American." This diversity poses a substantial challenge to creating standardized diagnostic criteria and can complicate visual assessment.

**2.2. Systemic and Logistical Hurdles**

Beyond diagnostic complexity, the field faces significant systemic and logistical problems in India that impact patient access and care quality.

* Shortage of Specialists: A critical issue is the scarcity of trained professionals. Dr. Sethy stated the statistic that India has less than one dermatologist per 1 lakh population, a ratio far below what is needed to serve the population.
* High Patient Load: This shortage leads to an immense patient load for practicing clinicians. Dr. Sethy recounted a personal anecdote from an outreach clinic where the waiting period for a consultation was seven to eight days, illustrating the overwhelming demand for dermatological care.
* Management of Chronic Diseases: Many common dermatological conditions, such as eczema, psoriasis, and vitiligo, are long-term and require frequent, time-consuming follow-up appointments. In a busy clinic, meticulously tracking disease progression and treatment response for dozens of chronic patients is a formidable task.

These compounding challenges—diagnostic subjectivity, workforce shortages, and the burden of chronic care—created a compelling case for technological intervention, positioning AI as a potential solution to some of dermatology's most entrenched problems.

---

## 3.0 The Advent of Artificial Intelligence (AI) in Dermatology

The entry of Artificial Intelligence into healthcare has been driven by the need to address persistent challenges like diagnostic ambiguity, workforce shortages, and the management of large-scale patient data. In this context, Dr. Sethy noted that dermatology was initially considered an ideal field for the application of AI, given its unique characteristics.


**3.1. Why Dermatology is a Prime Candidate for AI**

Dermatology appeared perfectly suited for AI integration primarily because it is a profoundly visual specialty. The diagnostic process relies heavily on analyzing images—clinical photographs, dermoscopy images (magnified views of skin lesions), and histopathology slides. This vast repository of visual data provides the raw material needed to train machine learning models. The initial, simplistic thinking, as Dr. Sethy summarized, was that "if a human can diagnose from a picture, a well-trained machine should be able to do the same."

**3.2. Current Role of AI in General Healthcare**

To provide a broader context, Dr. Sethy briefly summarized the expanding role of AI across the healthcare ecosystem. These applications include:

* Streamlining administrative tasks.
* Facilitating telemedicine consultations.
* Assisting in robotic surgery.
* Enabling remote patient monitoring of vital signs.
* Supporting medical research and chronic care management.

This widespread adoption in other medical areas created a strong expectation that AI would quickly revolutionize dermatology. However, the transition from theoretical potential to practical, everyday utility has revealed significant limitations and complexities.

---

## 4.0 Analysis of Current AI Applications and Their Limitations

This section provides a critical evaluation of existing AI tools and systems in dermatology. While some innovations show promise, Dr. Sethy's analysis reveals that they are far from being the comprehensive solutions once envisioned, with significant shortcomings that limit their clinical utility.

**4.1. Diagnostic and Dermoscopy Applications**

The most direct application of AI has been in developing tools for automated diagnosis from patient-submitted images.

* "Primitive" Mobile Apps: A number of mobile applications, such as SkinVision and DermaAids, allow users to upload photos of skin lesions for an instant diagnosis. However, Dr. Sethy assessed these tools as being in a "primitive stage." Their sensitivity and specificity are low, creating a dual risk: false positives can cause unnecessary patient anxiety, while false negatives (missed diagnoses of serious conditions like melanoma) can have devastating consequences.
* Key Innovation (DermaSensor): A more advanced and notable development is DermaSensor, a device that has received FDA approval in the United States for detecting skin cancers. It represents a significant step forward in hardware-based AI diagnostics. However, Dr. Sethy pointed out two key limitations for its application in India: it is not yet available in the country, and its research focus is almost exclusively on malignancies. This focus aligns with Western healthcare priorities but is less relevant to the Indian population, where inflammatory and infectious diseases are far more prevalent than skin cancer.

**4.2. Chronic Disease Management and Severity Assessment**

Managing chronic conditions requires objective tracking of disease progression, an area where AI could theoretically excel.

* The Follow-Up Challenge: Accurately tracking the evolution of diseases like psoriasis in a busy outpatient department is extremely difficult. It requires comparing the current state with previous visits, a time-consuming and subjective process.
* Scoring System Apps (e.g., Derm_score): To address this, apps like Derm_score have been developed to help clinicians calculate standardized severity indices, such as the Psoriasis Area and Severity Index (PASI). However, these tools fail to solve the core problem. As Dr. Sethy stated, "That's just a simple calculator what the app will do." The clinician must still perform the time-consuming and subjective visual assessment of redness and scaling, manually input the data, and only then does the app perform the final calculation. These apps digitize the final step instead of solving the fundamental challenges of visual assessment and data entry.

**4.3. AI in Niche Sub-Specialties**

AI is also being explored in various dermatological sub-specialties, though its impact remains limited.

* Cosmetic Dermatology: Skin analysis systems like VISIA use imaging to assess wrinkles, spots, and texture, while some modern lasers incorporate AI to guide treatment settings.
* Trichology (Hair Science): There is a notable absence of an automated system capable of analyzing trichoscopy images to count hair types, saving these images, and objectively comparing them over time to track treatment response.
* Dermatopathology: AI holds potential to assist pathologists in analyzing hundreds of tissue slides daily. However, current tools like VisualDX are still in a very early stage. They may help identify clinical patterns but do not offer definitive diagnostic support or correlate findings with other data types.

In summary, while progress has been made in specific areas, current AI tools are largely fragmented, single-purpose, and fall short of providing the comprehensive, integrated support that clinicians urgently need.

---

## 5.0 Overarching Limitations and Ethical Considerations

Beyond the shortcomings of specific applications, Dr. Mitanjali Sethy identified major technical and ethical barriers that prevent the widespread and reliable adoption of AI in dermatology. These challenges must be addressed for AI to fulfill its potential as a trusted clinical tool.

**5.1. Technical and Data-Related Barriers**

The performance of any AI system is fundamentally dependent on the data it is trained on, and in dermatology, this presents several unique problems.

* Data Quality and Diversity: AI requires high-quality, large, and diverse datasets to learn effectively. Dr. Sethy emphasized that AI struggles to account for morphological differences in how diseases present across various skin colors. Models trained primarily on Caucasian skin may perform poorly on Indian or African skin tones.
* Inability to Assess Tactile Features: A crucial part of a dermatological examination involves touch—feeling the texture, firmness, and depth of a lesion. She stated bluntly and powerfully, "A.I. can't feel the skin." This critical component of diagnosis, which provides information an image alone cannot convey, remains beyond the reach of current technology.
* Lack of Holistic Assessment: An AI model analyzes an image in isolation, whereas a clinician performs a holistic patient evaluation. The AI cannot consider the patient's history, lifestyle, and other contributing factors that are essential for an accurate diagnosis and effective treatment plan.

**5.2. Ethical, Legal, and Privacy Concerns**

The integration of AI into clinical practice also raises significant non-technical questions that must be resolved.

* Data Privacy and Consent: The use of patient images for training AI models brings up major issues of data privacy, security, and the need for informed consent.
* Accountability for Errors: Dr. Sethy posed a critical ethical question: who is responsible if an AI makes a diagnostic error that harms a patient? Is it the developer, the hospital, or the clinician who used the tool?
* Risk of Over-Reliance: There is a concern that excessive dependence on AI could lead to the degradation of a clinician's diagnostic skills. The highly trained "eagle eye" that defines a dermatologist's expertise is the very skill that is at risk of atrophy with over-reliance on automated systems.
* Regulatory Hurdles: The absence of standardized approval processes and clear legal and regulatory frameworks for medical AI devices creates uncertainty and hinders safe implementation.

To move forward, the development of AI in dermatology must go beyond technical innovation to include a forward-looking vision for how these tools can be built and used responsibly.

---

## 6.0 The Speaker's Wishlist: A Roadmap for Future AI Development

In direct response to the fragmented and limited state of current technology, Dr. Sethy articulated a forward-thinking "wishlist"—not as a futuristic fantasy, but as a pragmatic roadmap for developing AI that addresses the real-world needs of clinicians and patients.

**6.1. Core Functional Goals**

Dr. Sethy's primary goals focus on creating AI systems that augment, rather than replace, clinical expertise.

1. An Assistant, Not a Replacement: The core desire is for AI to function as a powerful screening tool. It should provide a list of differential diagnoses to assist the clinician's decision-making process, but it should not prescribe treatment.
2. Multimodal Data Integration: A truly intelligent system must be able to simultaneously analyze and correlate a patient's clinical, dermoscopic, and histopathological images. By integrating these different data streams for the same disease, the AI could arrive at a more accurate and comprehensive diagnostic suggestion.
3. Automated and Objective Scoring: There is an urgent need for a tool, perhaps a handheld scanner, that can automatically and objectively calculate disease severity scores like PASI. This would eliminate the subjectivity and significant time burden associated with manual calculations, allowing for consistent and efficient monitoring of chronic diseases.

**6.2. Innovative Applications and Tools**

Beyond these core functions, Dr. Sethy proposed several forward-thinking applications.

* Wearable Technology: She envisioned a wearable device, similar to a smartwatch, that could continuously monitor skin hydration and cumulative UV exposure. The device would alert the user when it's time to apply moisturizer or sunscreen, promoting proactive skin health.
* Pattern Recognition: Future AI should be sophisticated enough to recognize different clinical patterns of the same disease (e.g., mild vs. severe scabies). Crucially, it must also be able to identify "multiple different skin disorders... present in a particular person"—a task that can challenge the human eye when focused on one primary issue.
* Documentation Automation: To combat the daily administrative burden, she expressed a desire for tools that can automate the creation of clinical notes directly from voice dictation.

**6.3. Shifting the Research Focus**

A crucial part of her vision is a call to realign research priorities to better serve local needs.

* Beyond Skin Cancer: Dr. Sethy emphasized that AI research must move beyond its current overwhelming focus on skin cancer. Existing datasets are doubly inappropriate for the Indian context, focusing on both Western skin tones and disease priorities. Research efforts must be directed toward the inflammatory and infectious diseases that are far more prevalent in India and represent a greater public health burden.

This roadmap provides a clear direction for developing next-generation AI tools that are clinically relevant, ethically designed, and patient-centric.

---

## 7.0 Conclusion: A Call for Collaborative and Patient-Centric Innovation

In her concluding remarks, Dr. Mitanjali Sethy issued a powerful call for a new direction in the development of AI for dermatology. She stressed that true progress will only be achieved through deep and meaningful collaboration between clinicians and technologists. The ultimate goal must be to move beyond simply publishing papers to create tangible, end-to-end products that are genuinely useful in the daily lives of both doctors and patients. The focus should be on solving real-world problems—automating documentation, objectifying disease assessment, and providing reliable diagnostic support.

Dr. Sethy reiterated that many of the most critical areas, such as managing infectious and inflammatory diseases, remain "quite untouched" by research. This presents a vast and open opportunity for innovators to develop solutions that can truly transform dermatological care, enhance clinical efficiency, and ultimately improve patient outcomes on a global scale.
